Comparison

复旦中耳炎RS vs 鼻肿瘤康

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

复旦中耳炎RS

Features
Read full description

复旦中耳炎RS,是基于互联网技术面向中耳炎领域用户搭建的信息管理服务系统。 免责声明:在使用复旦中耳炎RS的过程中,您做出任何医疗决定之前,请优先寻求医生的建议!

About

鼻肿瘤康

Features
Read full description

鼻肿瘤康APP患者端软件是一款集定期随访、医生团队、患者随访、在线交流等功能为一体的鼻肿瘤术后康复全病程管理软件,可以通过此软件为有鼻肿瘤患者提供康复管理,软件结合图文与短视频方式提供了鼻肿瘤康复所需的资讯服务,以便患者用户学习和了解。

Screenshots

复旦中耳炎RS4 screens
鼻肿瘤康3 screens

Verdict

The call

The clearest difference is update cadence: 鼻肿瘤康 at every 10 days against 复旦中耳炎RS's every 5 weeks. On price, ads, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

复旦中耳炎RS ships an update every 5 weeks, 鼻肿瘤康 every 10 days. The most recent releases landed on September 30, 2026 and October 16, 2026 respectively.

Scorecard1 real difference · 5 level
复旦中耳炎RS versus 鼻肿瘤康: the parameters behind the verdict, then further details
Parameter复旦中耳炎RS鼻肿瘤康
PriceFreeFree
Update frequencyEvery 5 weeksEvery 10 days — better
AdsNoNo
In-app purchasesNoNo
DevicesiPhone, iPodiPhone, iPod
Requires iOS12.012.0
Further details — not scored
Size87 MB156 MB
Age rating12+12+
Developer复旦大学附属眼耳鼻喉科医院Shanghai SureeMed Technology Co., Ltd.

In-app purchases

None

复旦中耳炎RS

No in-app purchases

None

鼻肿瘤康

No in-app purchases

Questions

Is 复旦中耳炎RS free?
复旦中耳炎RS is free to download, with no in-app purchases.
Is 鼻肿瘤康 free?
鼻肿瘤康 is free to download, with no in-app purchases.
Do 复旦中耳炎RS or 鼻肿瘤康 have ads?
Neither 复旦中耳炎RS nor 鼻肿瘤康 shows ads.
Which is updated more often, 复旦中耳炎RS or 鼻肿瘤康?
复旦中耳炎RS ships an update every 5 weeks, and 鼻肿瘤康 every 10 days. Most recently, 复旦中耳炎RS was updated on September 30, 2026 and 鼻肿瘤康 on October 16, 2026.

Other comparisons